Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.6K Buy
76,338
+25,197
+49% +$21.5K ﹤0.01% 10923
2025
Q4
$69K Buy
+51,141
New +$51.5K ﹤0.01% 10375
2025
Q3
Sell
-13,644
Closed -$12.2K 11925
2025
Q2
$12.2K Buy
+13,644
New +$17.9K ﹤0.01% 9398
2023
Q2
Sell
-403
Closed -$28.3K 9699
2023
Q1
$28.3K Buy
+403
New +$37.4K ﹤0.01% 8583
2022
Q4
Sell
-233
Closed -$19K 10290
2022
Q3
$19K Buy
233
+167
+253% +$24K ﹤0.01% 9216
2022
Q2
$10K Buy
66
+36
+120% +$8.53K ﹤0.01% 9314
2022
Q1
$11K Buy
+30
New +$10.1K ﹤0.01% 10055
2021
Q4
Sell
-154
Closed -$115K 10910
2021
Q3
$115K Buy
+154
New +$129K ﹤0.01% 9219
2020
Q3
Sell
-338
Closed -$232K 8049
2020
Q2
$232K Buy
+338
New +$152K ﹤0.01% 6187
2019
Q2
Sell
-42
Closed -$67K 5852
2019
Q1
$67K Buy
+42
New +$66K ﹤0.01% 4803

Other funds holding YCBD

Jane Street's YCBD Position: Q1 2026 in Review

Jane Street increased its cbdMD (YCBD) stake by 49% in Q1 2026, buying an estimated $21.5K and bringing the position to 76,338 shares worth $56.6K. The position accounts for ﹤0.01% of the portfolio, ranked #10923.

Jane Street first reported a position in YCBD in Q1 2019 and has held it in 10 quarters since. The position peaked at $232K in Q2 2020. 25 funds tracked by Wall St. Rank hold YCBD as of Q1 2026.

  • Jane Street held 76,338 shares of cbdMD worth $56.6K as of Q1 2026.
  • Jane Street bought 25,197 cbdMD shares in Q1 2026, an estimated $21.5K.
  • cbdMD made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10923 holding.
  • Jane Street first reported a position in cbdMD in Q1 2019 and has held it in 10 quarters since.
  • Jane Street's cbdMD position peaked at $232K in Q2 2020.
  • 25 funds tracked by Wall St. Rank held cbdMD as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.